Related Experiment Video
Updated: Jun 18, 2025
05:57
Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
Published on: May 17, 2024
710
HYPERHOMOCYSTEINEMIA AS A CAUSE OF ERECTILE DYSFUNCTION.
G Bruk1, F Rostomov1, D Tyulekbayeva1
1NWSMU named after I.I. Mechnikova, Saint-Petersburg; First Pavlov State Medical University of St. Petersburg, Russia.
Georgian Medical News
|August 1, 2024
Summary
Elevated homocysteine levels (hyperhomocysteinaemia) are linked to endothelial damage and cardiovascular issues. This study reveals hyperhomocysteinaemia as a molecular mechanism contributing to erectile dysfunction (ED) in men.
Area of Science:
- Cardiovascular Science
- Metabolic Disorders
- Urology
Background:
- Hyperhomocysteinaemia, elevated blood homocysteine, has been studied since the mid-20th century.
- Early research linked homocysteinuria to cystathionine-beta-synthase defects and atherosclerosis.
- McQuilley's
- homocysteine
- theory of atherosclerosis (1969) proposed its role in vascular damage.
Purpose of the Study:
- To investigate the association between hyperhomocysteinaemia and erectile dysfunction (ED).
- To explore hyperhomocysteinaemia as a potential molecular mechanism underlying ED.
Main Methods:
- Utilized patient analyses and laboratory data.
- Employed statistical research methods, including analysis and synthesis.
- Focused on homocysteine levels as a key marker in a multidisciplinary hospital setting.
Main Results:
- Demonstrated that hyperhomocysteinaemia contributes to endothelial damage in blood vessels.
- Established a correlation between elevated homocysteine levels and the development of erectile dysfunction.
- Identified hyperhomocysteinaemia as a molecular mechanism implicated in ED pathogenesis.
Conclusions:
- Hyperhomocysteinaemia is a significant factor in the development of erectile dysfunction.
- Understanding this link can inform clinical approaches to managing ED.
- Further research into homocysteine metabolism may yield new therapeutic strategies for vascular and erectile health.
Related Concept Videos
01:20Disorders of the Male Reproductive System
373
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
373
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
69
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
69
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
141
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
141
01:17Male Sexual Response: Erection & Ejaculation
1.9K
Sexual stimulation can take various forms, such as physical touch and visual or auditory cues. When this happens, the parasympathetic reflex in the sacral portion of the spinal cord is activated. This reflex stimulates the release of nitric oxide (NO), which then dilates the arterioles in the penis, increasing blood flow to the erectile tissues - the corpora cavernosa and corpus spongiosum.
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
1.9K
01:23Infertility in Males
256
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
256
01:28Nitric Oxide Signaling Pathway
5.0K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.0K